COVID-19;Long COVID;Paxlovid;anti-viral drug;rebound symptoms;test positivity

Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID

[ad_1] Newswise — A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the…